Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
The Risky Business of Limiting Medicaid Access to Sovaldi

Partially because of its high cost, nearly half the states are restricting Medicaid patients' access to an effective new hepatitis C drug. Experts say there’s no question lawsuits will come.

Published
20 hours ago
From
Governing
New report finds missing and incomplete data imperils the global HIV/AIDS response

A new report from amfAR, The Foundation for AIDS Research, and AVAC outlines the need for a new approach to tracking data to guide the key decisions that shape the response to the HIV/AIDS epidemic. Critical and expensive decisions made with incomplete data are undermining the response—even as the systems for collecting this data continue to improve, the report found.

Published
21 hours ago
From
AVAC
Global Fund Investment Guidance for Eastern Europe and Central Asia

The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.

Published
21 hours ago
From
Global Fund to Fight AIDS, TB and Malaria
Kenya: Young women lead in new HIV infections - study

Women aged between 15 and 24 years account for 21 per cent of new HIV infections in the country, a new report says. The report says approximately 88,620 new HIV infections occurred among adults and 12,940 among children last year.

Published
21 hours ago
From
The Standard Digital News
PEPFAR’s South Africa “transition”: Nearly 20 percent of patients went unaccounted for when care was transferred, study finds

Survey finding gaps in care, records during transfer of patients from PEPFAR-supported program to community-based clinics comes as new report cites need for data.

Published
19 August 2014
From
Science Speaks
AIDS Activist Takes up a New Fight: Defending FDA

As an AIDS activist in the early 1990s, Gregg Gonsalves traveled to Washington to challenge the Food and Drug Administration. Gonsalves was part of the confrontational group AIDS Coalition to Unleash Power, which staged protests outside the FDA's headquarters, disrupted its public meetings and pressured its leaders into speeding up the approval of experimental drugs for patients dying of AIDS. A quarter century later, Gonsalves still travels to Washington, but with a different agenda: to defend the FDA.

Published
13 August 2014
From
ABC
Brazil Sees Rise In HIV Cases

Even as HIV infection rates have begun declining in many other places, cases have been slowly rising in Brazil — with the sharpest jump among youths 15 to 24.

Published
12 August 2014
From
Huffington Post
Gilead in talks with Indian drugmakers to sell Sovaldi at cut-rate prices

Share Tools Comment Print Contact Author Reprint Indian drugmakers have a shot at bringing Gilead Sciences' ($GILD) hot new hepatitis C drug to their country. The California-based company is in talks with "a handful" of Indian pharmas to take Sovaldi (sofosbuvir) to that country and other developing nations at a fraction of the U.S. price.

Published
11 August 2014
From
Fierce Pharma
An Activist's Welcome -- and a Friendly Challenge -- to NYC's New HIV Head

Now a high-level appointment at New York City's Department of Health and Mental Hygiene has given city activists hope that the department is getting serious about countering the epidemic in new HIV infections among men who have sex with men.

Published
08 August 2014
From
The Body
MSF: Untangling the web of antiretroviral price reductions, 17th Edition

This 17th edition of Untangling the Web of Antiretroviral Price Reductions is a departure from recent previous years. The information is presented in a new, shorter format focusing on a few key drugs as well as future regimens, along with an analysis of the current opportunities, challenges and threats faced in keeping the price of ARVs down.

Published
08 August 2014
From
MSF
← First12345...437Next →

Filter by country